297 related articles for article (PubMed ID: 23943725)
1. Aspirin and salicylate in respiratory disease.
Mitchell JE; Skypala I
Rhinology; 2013 Sep; 51(3):195-205. PubMed ID: 23943725
[TBL] [Abstract][Full Text] [Related]
2. Aspirin-exacerbated respiratory disease: update on pathogenesis and desensitization.
White AA; Stevenson DD
Semin Respir Crit Care Med; 2012 Dec; 33(6):588-94. PubMed ID: 23047310
[TBL] [Abstract][Full Text] [Related]
3. [Long-term efficacy of aspirin desensitization in aspirin-exacerbated respiratory disease. Review of two clinical cases].
Cambray-Gutiérrez JC; García-Ramírez UN; Del Rivero-Hernández LG; Lozano-Martínez SA; López-Pérez P; Chávez-García A
Rev Alerg Mex; 2016; 63(2):207-12. PubMed ID: 27174764
[TBL] [Abstract][Full Text] [Related]
4. Comparable safety of 2 aspirin desensitization protocols for aspirin exacerbated respiratory disease.
Pelletier T; Roizen G; Ren Z; Hudes G; Rosenstreich D; Jerschow E
J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1319-1321. PubMed ID: 30144584
[No Abstract] [Full Text] [Related]
5. Aspirin or other nonsteroidal inflammatory agent exacerbated asthma.
Ledford DK; Wenzel SE; Lockey RF
J Allergy Clin Immunol Pract; 2014; 2(6):653-7. PubMed ID: 25439353
[TBL] [Abstract][Full Text] [Related]
6. Evidence-based approach to aspirin desensitization in aspirin-exacerbated respiratory disease.
Woessner KM; White AA
J Allergy Clin Immunol; 2014 Jan; 133(1):286-7.e1-9. PubMed ID: 24369807
[No Abstract] [Full Text] [Related]
7. Aspirin exacerbated respiratory disease: Current topics and trends.
Rodríguez-Jiménez JC; Moreno-Paz FJ; Terán LM; Guaní-Guerra E
Respir Med; 2018 Feb; 135():62-75. PubMed ID: 29414455
[TBL] [Abstract][Full Text] [Related]
8. [Aspirin-exacerbated respiratory disease].
Randerath WJ
Dtsch Med Wochenschr; 2013 Mar; 138(11):541-7. PubMed ID: 23463477
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis Exploring Sinopulmonary Outcomes of Aspirin Desensitization in Aspirin-Exacerbated Respiratory Disease.
Chaaban MR; Moffatt D; Wright AE; Cowthran JA; Hsu ES; Kuo YF
Otolaryngol Head Neck Surg; 2021 Jan; 164(1):11-18. PubMed ID: 32571140
[TBL] [Abstract][Full Text] [Related]
10. Aspirin desensitization achieved after omalizumab treatment in a patient with aspirin-exacerbated urticaria and respiratory disease.
Guillén D; Bobolea I; Calderon O; Fiandor A; Cabañas R ; Heredia R; Quirce S
J Investig Allergol Clin Immunol; 2015; 25(2):133-5. PubMed ID: 25997307
[No Abstract] [Full Text] [Related]
11. Aspirin-Exacerbated Respiratory Disease.
White AA; Stevenson DD
N Engl J Med; 2018 Sep; 379(11):1060-1070. PubMed ID: 30207919
[No Abstract] [Full Text] [Related]
12. Aspirin-exacerbated respiratory disease: not always "adult-onset".
Tuttle KL; Schneider TR; Henrickson SE; Morris D; Abonia JP; Spergel JM; Laidlaw TM
J Allergy Clin Immunol Pract; 2016; 4(4):756-8. PubMed ID: 27393784
[No Abstract] [Full Text] [Related]
13. Co-treatment of non-steroidal anti-inflammatory drug-exacerbated respiratory disease with dupilumab and aspirin therapy after desensitization.
Buchheit KM; Hacker J; Maurer R; McGill A; Ryan T; Bensko JC; Laidlaw TM
Clin Exp Allergy; 2023 Sep; 53(9):974-977. PubMed ID: 37246613
[No Abstract] [Full Text] [Related]
14. Aspirin desensitization in aspirin-exacerbated respiratory disease.
White AA; Stevenson DD
Immunol Allergy Clin North Am; 2013 May; 33(2):211-22. PubMed ID: 23639709
[TBL] [Abstract][Full Text] [Related]
15. Aspirin desensitization for patients with aspirin-exacerbated respiratory disease: A randomized double-blind placebo-controlled trial.
Esmaeilzadeh H; Nabavi M; Aryan Z; Arshi S; Bemanian MH; Fallahpour M; Mortazavi N
Clin Immunol; 2015 Oct; 160(2):349-57. PubMed ID: 26083948
[TBL] [Abstract][Full Text] [Related]
16. Aspirin-exacerbated respiratory disease: characteristics and management strategies.
Simon RA; Dazy KM; Waldram JD
Expert Rev Clin Immunol; 2015; 11(7):805-17. PubMed ID: 25936612
[TBL] [Abstract][Full Text] [Related]
17. Intranasal ketorolac-induced pancreatitis as a complication of modified oral aspirin desensitization in a patient with aspirin-exacerbated respiratory disease.
Luskin KT; Bosso JV; Simon RA
J Allergy Clin Immunol Pract; 2020 Mar; 8(3):1147-1148. PubMed ID: 31678291
[No Abstract] [Full Text] [Related]
18. The effect of aspirin desensitization on novel biomarkers in aspirin-exacerbated respiratory diseases.
Katial RK; Strand M; Prasertsuntarasai T; Leung R; Zheng W; Alam R
J Allergy Clin Immunol; 2010 Oct; 126(4):738-44. PubMed ID: 20728206
[TBL] [Abstract][Full Text] [Related]
19. Failure of tacrolimus to prevent aspirin-induced respiratory reactions in patients with aspirin-exacerbated respiratory disease.
Stevenson DD; Mehra PK; White AA; Gupta S; Woessner KM; Simon RA
J Allergy Clin Immunol; 2005 Oct; 116(4):755-60. PubMed ID: 16210047
[TBL] [Abstract][Full Text] [Related]
20. The prevalence of aspirin hypersensitivity in patients with nasal polyposis and contributing factors.
Bavbek S; Dursun B; Dursun E; Korkmaz H; Sertkaya Karasoy D
Am J Rhinol Allergy; 2011; 25(6):411-5. PubMed ID: 22185746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
